Ionis Pharmaceuticals Inc (IONS) Down 7.41% in Premarket Trading

Ionis Pharmaceuticals Inc (IONS) is down Monday morning, with the stock declining -7.41% in pre-market trading to 32.5. IONS's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 59% of stocks. Ionis Pharmaceuticals Inc has fallen 5.67% over the past month, closing at $36.19 on September 20. During this period of time, the stock fell as low as $32.33 and as high as $37.47. IONS has an average analyst recommendation of Buy. The company has an average price target of $49.41.

IONS has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on IONS!

See Full IONS Report

Ionis Pharmaceuticals Inc has a Long-Term Technical rank of 15. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 85% of the market scoring higher. In the Biotechnology industry which is number 135 by this metric, IONS ranks better than 41% of stocks.

Important Dates for Investors in IONS:

-Ionis Pharmaceuticals Inc is set to release earnings on 11/2/2021. During their last earnings release the company posted EPS of $-3.86. -We do not have a set dividend date for Ionis Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Ionis Pharmaceuticals Inc (IONS)